Current role
Biotechnology · Healthcare
Chief Accounting Officer
2026-08-10–present
Robert W. Gunning
Chief Accounting Officer
NewAmsterdam Pharma Co N.V. (NAMS)Equibles does not estimate personal net worth.
Get an email with a short summary when NewAmsterdam Pharma Co N.V. publishes a filing, an earnings call transcript or a press release.
Get NAMS alertsAbout Robert W. Gunning
Robert W. Gunning is recorded as Chief Accounting Officer at NewAmsterdam Pharma Co N.V. (NAMS) since August 10, 2026. NewAmsterdam Pharma Co N.V. reported in an 8-K filed August 14, 2026 that Robert W. Gunning was appointed principal accounting officer, effective August 10, 2026. NewAmsterdam Pharma Co N.V. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at NewAmsterdam Pharma Co N.V. includes Michael Davidson (CEO), Willian H. Lewis, J.D., M.B.A. (Chairman), Ian Somaiya (CFO) and 3 others.
“On August 10, 2026, NewAmsterdam Pharma Company N.V. (the "Company") appointed Robert W. Gunning, age 55, as its principal accounting officer.”
Affiliation history
-
Current
2026-08-10–present
Company network
Leadership on record at NewAmsterdam Pharma Co N.V.
- Michael Davidson CEO
- Willian H. Lewis, J.D., M.B.A. Chairman
- Ian Somaiya CFO
- Adele Gulfo Board Member
- Mark C. McKenna Board Member
- Wouter Joustra Board Member